EcoDrugPlus

Ensembl ID : ENSDLAG00005007091
Gene Symbol: -
Cross references: -
231 Possible Orthologues:

Ensembl ID : ENSDLAG00005007099
Gene Symbol: -
Cross references: -
231 Possible Orthologues:

Ensembl ID : ENSDLAG00005009621
Gene Symbol: -
Cross references: -
412 Possible Orthologues:

Ensembl ID : ENSDLAG00005032590
Gene Symbol: -
Cross references: -
172 Possible Orthologues:

Ensembl ID : ENSDLAG00005000683
Gene Symbol: -
Cross references: -
372 Possible Orthologues:

Ensembl ID : ENSDLAG00005000902
Gene Symbol: -
Cross references: -
263 Possible Orthologues:

Ensembl ID : ENSDLAG00005000951
Gene Symbol: -
Cross references: -
183 Possible Orthologues:

Ensembl ID : ENSDLAG00005000983
Gene Symbol: -
Cross references: -
257 Possible Orthologues:

Ensembl ID : ENSDLAG00005001112
Gene Symbol: -
Cross references: -
168 Possible Orthologues:

Ensembl ID : ENSDLAG00005001123
Gene Symbol: -
Cross references: -
205 Possible Orthologues:

Ensembl ID : ENSDLAG00005001164
Gene Symbol: -
Cross references: -
218 Possible Orthologues:

Ensembl ID : ENSDLAG00005001449
Gene Symbol: -
Cross references: -
195 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).